Biocon Biologics' new mAbs facility receives EU GMP Certification for bBevacizumab
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The appointment is effective from May 01, 2023 for five years
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
The business and product range of Ipca and that of Unichem complements each others business and product range
Metronidazole is an antibiotic used on the skin to treat a certain skin disorder known as rosacea
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
Subscribe To Our Newsletter & Stay Updated